Podcast with board member Ted Fjällman
On a recent episode of Värdeskaparna, NorthX Biologics very own board member Ted Fjällman made a quest appearance. During the podcast, Ted delves into the biotech industry’s current trends and ...
Listen to Q podden with Janet Hoogstraate
We’re thrilled to share that Janet Hoogstraate, the CEO of NorthX Biologics, has recently appeared in an episode of Q-podden! 🎧 In this engaging podcast, Janet discusses the latest trends and innovations ...
Ensuring every child is vaccinated
On behalf of the Swedish Ministry for Foreign Affairs and Gavi, the Global Vaccine Alliance, NorthX Biologics’ CEO Janet Hoogstraate participated in an important roundtable on “Leveraging Technology and Innovation to Ensure Every ...
The rise of the CDMO era – an investor’s perspective
Based on a presentation given by Thomas Eldered at the PharmaOutsourcing event, Stockholm Sweden, December 2024. From vertical integration to decentralization The pharmaceutical industry has undergone a seismic shift over ...
New podcast with Thomas Beck
We’re excited to announce that Thomas Beck, the Chief Quality Officer (CQO) at NorthX Biologics, has recently been featured in an episode of Q-podden! In this podcast, Thomas shares valuable insights into ...
Navigating the complexities of microbial and mammalian manufacturing
With a rich historical legacy and decades of expertise at its two sites, NorthX Biologics has long mastered the complexities of microbial and mammalian manufacturing. By offering capabilities and differentiating ...
Navigating Novo Nordisk’s acquisition of Catalent
In this episode of the Molecule to Market podcast, NorthX Biologics CEO Janet Hoogstraate was invited to discuss the implications of integrating Catalent’s capabilities into Novo Nordisk’s operations and what ...
Advancing the science of technical and therapeutic proteins
NorthX Biologics is at the forefront of technical and therapeutic protein development, playing a critical role in supporting the production of advanced therapies. With over three decades of expertise, NorthX ...
Navigating the regulatory and manufacturing realities of mRNA therapeutic development
The increasingly dynamic and multifaceted landscape of mRNA therapeutics is posing new regulatory and manufacturing challenges. Both startups and established biopharma companies require innovative solutions to help them meet the ...